Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Recently, I was reading Luca Dezzani’s article “Patient Engagement: A Key Element in Pharmaceutical Marketing Strategy.” The article prompted me to think about how pharma companies continue to think about and discuss the idea of Patient Engagement, and.... Read More »

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Best Practices, LLC has recently completed “Benchmarking Regulatory Affairs Staffing & Performance Excellence in Medical Devices,” a new operational benchmarking study. After analyzing the data and probing the experience of 30 regulatory affairs (RA).... Read More »

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Read More »

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

At Pharma CI Conference 2015 in New Jersey, Best Practices, LLC’s CEO, Chris Bogan discussed the topic: Blockbuster Drugs Launch Evolution: Mapping Market - Entry Changes That Cause New Products to Stumble or Soar.... Read More »

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. Read More »

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. Read More »

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. Read More »

Brand Lifecycle Management: Strategies for Every Budget

Brand Lifecycle Management: Strategies for Every Budget

Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels from survey results of 25 executives representing 18 companies. Read More »

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple’s announcement that it will begin providing healthcare to its employees and families offers one more reason that Medical Affairs groups should ramp up their efforts to work with Large Employer groups. Read More »

 

Leveraging Medical Analytics for Better Outcomes

The healthcare industry is witnessing a transformative shift fueled by advanced medical analytics. Imagine unlocking insights that redefine strategies, optimize product launches, and ultimately enhance patient outcomes and care models. It’s not just a vision—it’s a reality for forward-thinking Medical

Beyond the Pill: Improving Patient Medication Adherence

Despite advancements in treatment modalities and support services, patient adherence rates often plateau, leaving both patients and healthcare providers grappling with suboptimal outcomes. Shockingly, adherence rates for brands can plummet to as low as 60%. The journey towards optimal adherence

Elevating Standards: Industry Benchmarks on Building Medical Excellence Groups

In today’s rapidly evolving healthcare landscape, Medical Excellence (Med X) groups play a pivotal role in driving transformation within Medical Affairs. These groups are instrumental in both tactical and strategic phases of evolution. During their inception, Med X teams focus

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 4 of New Series

Author:

Let’s be real, 2020 has been a hard year. It’s hard to know what to do or what not to do; it’s hard to navigate business decisions, when it’s NOT business as usual. We want you to know that while

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 3 of New Series

Author:

Let’s be real, 2020 has been a difficult year thus far. We see people hunkering down, their focus shifting and some reticence to make decisions. Best Practices has felt these seismic shifts as well, but one thing that has not

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 2 of New Series

Author:

2020 has been a difficult year, but the need for speed in making business decision is becoming more critical. Best Practices recognizes that seismic shifts in how business is conducted are facing all companies, and we want to re-confirm our

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 1 of New Series

Author:

Let’s be real, 2020 has been a hard year for most of us. It’s hard to know what to do or what not to do; it’s hard to navigate business decisions, when it’s NOT business as usual. We see people

How Elite Medical Affairs Teams Help Drive a Successful Pharma Product Launch

A highly regulated marketplace, coupled with intensifying competition, have pushed the Medical Affairs function into a significant launch role that extends from the pre-launch phases to well beyond market entry. Best-in-class Medical Affairs groups can become a kind of conduit

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple’s announcement that it will begin providing healthcare to its employees and families offers one more reason that Medical Affairs groups should ramp up their efforts to work with Large Employer groups. Apple’s announcement for AC Wellness follows on the heels of

Brand Lifecycle Management: Strategies for Every Budget

At every investment level, superior strategies emerge Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels

Evidence-based Tactics Impact TRx Growth

Co-pay and adherence programs continue to be the most effective tactics to drive TRx pull through Many pharmaceutical companies use co-pay cards and adherence programs as individual tactics in their patient support programs, but health care consultancies Best Practices, LLC

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Author:

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. While this

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. For decades, disease awareness campaigns were a part of the playbook for educating physicians and patients about new

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. It